A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Filgotinib (Primary)
- Indications Crohn's disease; Rectal fistula
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 08 May 2017 New source identified and integrated: European Clinical Trials Database (EudraCT2016-003153-15).
- 13 Apr 2017 Status changed from not yet recruiting to recruiting.
- 15 Mar 2017 Status changed to not yet recruiting.